{"id":53217,"date":"2023-09-20T09:43:58","date_gmt":"2023-09-20T09:43:58","guid":{"rendered":"https:\/\/medsname.com\/cyclophil-me\/"},"modified":"2026-04-30T16:30:27","modified_gmt":"2026-04-30T16:30:27","slug":"cyclophil-me","status":"publish","type":"product","link":"https:\/\/medsbase.com\/ro\/product\/cyclophil-me\/","title":{"rendered":"Cyclophil Me"},"content":{"rendered":"<div class=\"medsbase-tldr-answer\" style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:14px 18px;margin:18px 0;border-radius:4px;\">\n<h3 style=\"margin-top:0;\">R\u0103spuns rapid<\/h3>\n<p style=\"margin-bottom:0;\"><strong>Cyclophil ME<\/strong> \u2014 Ciclosporin\u0103 ME (Microemulsie) 25\/50\/100 mg (Sun Pharma). Inhibitor de calcineurin\u0103 (formulare sub form\u0103 de microemulsie) pentru imunosupresie de men\u021binere la transplanturi de organe solide, dermatit\u0103 atopic\u0103 sever\u0103, psoriazis refractar, artrit\u0103 reumatoid\u0103 sever\u0103, sindrom de ochi uscat (topic), sindrom nefrotic. Este necesar\u0103 monitorizarea terapeutic\u0103 a medicamentului.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f7f7f7;border-left:4px solid #2c7cb0;padding:14px 18px;margin:18px 0;border-radius:4px;\">\n<p style=\"margin:0 0 6px 0;\"><strong>Ce beneficii ofer\u0103 MedsBase:<\/strong><\/p>\n<ul style=\"margin:6px 0 0 22px;padding:0;list-style:disc;\">\n<li>produc\u0103tor certificat WHO-GMP<\/li>\n<li>Ambalaj discret \u00een plic simplu<\/li>\n<li>Livrare \u00een toat\u0103 lumea<\/li>\n<li>Evaluat de peste 1.400 de clien\u021bi (<a href=\"https:\/\/medsbase.com\/ro\/reviews\/\">cite\u0219te recenziile<\/a>)<\/li>\n<\/ul>\n<\/div>\n<p class=\"medsbase-reship-line\" style=\"background:#eef7ee;border-left:4px solid #4caf50;padding:10px 14px;margin:14px 0;border-radius:3px;\">\ud83d\udce6 <strong>Garan\u021bia de retransmitere:<\/strong> dac\u0103 comanda dvs. nu a ajuns \u00een 20 de zile lucr\u0103toare de la expediere, o retransmitem f\u0103r\u0103 costuri suplimentare. <a href=\"https:\/\/medsbase.com\/ro\/medsbase-re-shipment-assurance-policy\/\">Cite\u0219te politica<\/a>.<\/p>\n<h3>De ce s\u0103 comanzi de la MedsBase<\/h3>\n<p>Cyclophil ME este expediat de la un produc\u0103tor certificat WHO-GMP \u00een ambalaj neutru, facturat prin intermediul unui procesor de pl\u0103\u021bi reglementat (descrierea extrasului de cont men\u021bioneaz\u0103 un procesor de pl\u0103\u021bi cu card reglementat \u2014 niciodat\u0103 MedsBase sau numele vreunui medicament). Fiecare comand\u0103 beneficiaz\u0103 de Garan\u021bia noastr\u0103 de Retrimitere \u00een 20 de zile lucr\u0103toare.<\/p>\n<div class=\"medsbase-specialist-strip\" style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:14px 18px;margin:18px 0;border-radius:4px;\">\n<p style=\"margin:0;\"><strong>\u26a0\ufe0f Terapie oncologic\u0103 supravegheat\u0103 de specialist<\/strong> \u2014 acest medicament este ini\u021biat, monitorizat \u0219i \u00eentrerupt de un oncolog sau hematolog. Dozarea depinde de tipul tumorii, stadiul, suprafa\u021ba corporal\u0103, func\u021bia organelor \u0219i terapia concomitant\u0103. Autotratamentul nu este adecvat; informa\u021biile de mai jos au scop educa\u021bional \u0219i sus\u021bin conversa\u021biile informate cu specialistul dumneavoastr\u0103.<\/p>\n<\/div>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:12px 16px;margin:14px 0;border-radius:3px;\"><strong>Monitorizare specializat\u0103 necesar\u0103<\/strong><br \/>Imunosupresoarele necesit\u0103 supraveghere specializat\u0103 continu\u0103 (transplant, reumatologie sau hematologie). Nivelurile medicamentoase (ciclosporin\u0103, sirolimus, tacrolimus), hemograma complet\u0103, func\u021bia hepatic\u0103, func\u021bia renal\u0103, lipidele, glicemia, tensiunea arterial\u0103 \u2014 toate necesit\u0103 monitorizare regulat\u0103. Supravegherea infec\u021biilor este obligatorie. Starea de vaccinare trebuie optimizat\u0103 \u00eenainte de \u00eenceperea terapiei; vaccinurile cu virus viu sunt contraindicate \u00een timpul tratamentului.<\/div>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:12px 16px;margin:14px 0;border-radius:3px;\"><strong>Risc de infec\u021bie + supraveghere oncologic\u0103<\/strong><br \/>Imunosupresia pe termen lung cre\u0219te riscurile: infec\u021bii oportuniste (PCP, CMV, PTLD determinat de EBV), infec\u021bii bacteriene\/fungice, reactivarea tuberculozei latente sau a HBV\/HCV. Riscul crescut de cancer de piele (\u00een special carcinom scuamos), boal\u0103 limfoproliferativ\u0103 \u0219i alte neoplasme. Verific\u0103ri anuale ale pielii, supraveghere oncologic\u0103 regulat\u0103 conform ghidurilor.<\/div>\n<h2 id=\"faqs\">\u00centreb\u0103ri frecvente<\/h2>\n<h3>C\u00e2nd se utilizeaz\u0103?<\/h3>\n<p>Inhibitor de calcineurin\u0103 (formulare microemulsie) pentru imunosupresie de \u00eentre\u021binere la transplant de organe solide, dermatit\u0103 atopic\u0103 sever\u0103, psoriazis refractar, artrit\u0103 reumatoid\u0103 sever\u0103, sindrom de ochi uscat (topic), sindrom nefrotic. Este necesar monitorizarea terapeutic\u0103 a medicamentului. \u00centotdeauna sub supraveghere specializat\u0103 \u2014 \u00een context de transplant, reumatologie, hematologie sau oncologie.<\/p>\n<h3>De ce este necesar\u0103 monitorizarea?<\/h3>\n<p>Monitorizarea terapeutic\u0103 a medicamentului (ciclosporin\u0103, sirolimus, tacrolimus): nivelurile reziduale \u021bintesc protec\u021bia organelor f\u0103r\u0103 toxicitate. Func\u021bia renal\u0103: majoritatea sunt nefrotoxice. Lipide\/glucoz\u0103: efecte metabolice. Hemogram\u0103 complet\u0103: suprimare medular\u0103.<\/p>\n<h3>Interac\u021biuni medicamentoase?<\/h3>\n<p>Clas\u0103 critic\u0103 \u2014 substraturi puternice ale CYP3A4 (inhibitori de calcineurin\u0103, inhibitori mTOR). Multe interac\u021biuni: antifungicele cresc nivelurile (adesea dramatic \u2014 chiar de 5-10 ori), rifampicina scade nivelurile (risc de respingere), grapefruitul cre\u0219te nivelurile. Orice medicament nou ar trebui verificat \u00een prealabil.<\/p>\n<h3>Vaccinuri?<\/h3>\n<p>Vaccinuri inactivate acceptabile; vaccinurile vii sunt contraindicate \u00een timpul terapiei. Optimiza\u021bi vaccin\u0103rile \u00ceNAINTE de a \u00eencepe \u2014 pneumococic, grip\u0103 anual\u0103, hepatit\u0103 B, varicel\u0103, ROR, HPV dup\u0103 caz.<\/p>\n<h3>Sarcin\u0103?<\/h3>\n<p>Micofenolatul este teratogen \u2014 contracep\u021bie strict\u0103. Ciclosporina, tacrolimus, azatioprina sunt utilizate \u00een sarcin\u0103 sub supraveghere specializat\u0103. Inhibitorii mTOR sunt \u00een general evita\u021bi. Discuta\u021bi \u00eentotdeauna planificarea familiei cu specialistul.<\/p>\n<h3>Screening pentru cancer?<\/h3>\n<p>Controle cutanate la fiecare 6-12 luni (risc pe via\u021b\u0103 de cancer de piele). Citologie cervical\u0103 mai frecvent\u0103. Ganglioni limfatici \u2014 monitorizare pentru boli limfoproliferative.<\/p>\n<h3>Infec\u021bii?<\/h3>\n<p>Profilaxie cu cotrimoxazol pentru PCP \u00een primele 6-12 luni post-transplant. Monitorizare CMV. Screening pentru TB \u00eenainte de \u00eencepere. Vigilen\u021b\u0103 continu\u0103 pentru infec\u021bii \u2014 febr\u0103 necesit\u0103 evaluare prompt\u0103.<\/p>\n<h3>Protec\u021bie solar\u0103?<\/h3>\n<p>SPF 50+ cu spectru larg zilnic \u00eencep\u00e2nd cu ziua transplantului. Revizie dermatologic\u0103 anual\u0103. Cancerul de piele este cea mai frecvent\u0103 malignitate post-transplant.<\/p>\n<h3>Ce fac dac\u0103 uit o doz\u0103?<\/h3>\n<p>Lua\u021bi c\u00e2nd v\u0103 aminti\u021bi dac\u0103 este aceea\u0219i zi; dac\u0103 \u00eent\u00e2rzia\u021bi &gt;12 ore, omite\u021bi \u0219i relua\u021bi urm\u0103toarea doz\u0103. Nu dubla\u021bi doza. Nivelurile constante sunt importante \u2014 discuta\u021bi aderen\u021ba cu echipa de transplant.<\/p>\n<h3>\u00centrerupere?<\/h3>\n<p>Nu opri\u021bi niciodat\u0103 f\u0103r\u0103 \u00eendrumare specializat\u0103 \u2014 risc\u0103 respingere acut\u0103 (transplant) sau exacerbare a bolii (autoimun). Reducerea treptat\u0103 se face pe parcursul lunilor, nu a zilelor, \u0219i numai c\u00e2nd este clinic oportun.<\/p>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h2>Alte Medicamente Imunosupresoare &amp; pentru Cancer<\/h2>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/ro\/mycept\/\">Mycept<\/a> \u2014 mycophenolate mofetil 250 mg \u2014 marc\u0103 alternativ\u0103 de MMF<\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/mycofit\/\">Mycofit<\/a> \u2014 mycophenolate mofetil 500 mg<\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/cyclophil-me\/\">Cyclophil ME<\/a> \u2014 ciclosporin\u0103 ME 25\/50\/100 mg<\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/renodapt-s\/\">Renodapt S<\/a> \u2014 micofenolat de sodiu 360 mg \u2014 cu \u00eenveli\u0219 enteric<\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/rapact\/\">Rapact<\/a> \u2014 sirolimus 5\/10 mg \u2014 inhibitor mTOR<\/li>\n<\/ul>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:12px 16px;margin:18px 0;border-radius:3px;font-size:.95em;\"><strong>Disclaimer medical:<\/strong> Tratamentul cancerului este foarte individualizat. Medicamentul specific, doza, programul, monitorizarea \u0219i \u00eengrijirea de sus\u021binere trebuie stabilite de un oncolog sau hematolog calificat, pe baza biologiei tumorii, stadializ\u0103rii, comorbidit\u0103\u021bilor \u0219i obiectivelor terapiei. Aceast\u0103 informa\u021bie are caracter educa\u021bional; nu \u00eenlocuie\u0219te sfatul medical profesionist.<\/div>","protected":false},"excerpt":{"rendered":"<p>Cyclophil ME (Ciclosporin\u0103 25\/50\/100 mg) \u2014 inhibitor de calcineurin\u0103 sub form\u0103 de microemulsie de la Sun Pharma pentru men\u021binerea transplantului, dermatit\u0103 atopic\u0103 sever\u0103, psoriazis refractar, artrit\u0103 reumatoid\u0103. Monitorizarea terapeutic\u0103 a medicamentului este esen\u021bial\u0103.<\/p>","protected":false},"featured_media":53218,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3595,3141,3223],"product_tag":[],"class_list":{"0":"post-53217","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-anti-cancer-medication","7":"product_cat-category-overview","8":"product_cat-chronic-conditions","10":"first","11":"outofstock","12":"shipping-taxable","13":"purchasable","14":"product-type-variable","15":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product\/53217","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/comments?post=53217"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media\/53218"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media?parent=53217"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_brand?post=53217"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_cat?post=53217"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_tag?post=53217"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}